← Back to Clinical Trials
Recruiting NCT05606432

NCT05606432 Cardiometabolic Health Intervention Using Movement-to-Music Exercise

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05606432
Status Recruiting
Phase
Sponsor University of Alabama at Birmingham
Condition Cardiometabolic Risk Factors in Adult Wheelchair Users
Study Type INTERVENTIONAL
Enrollment 132 participants
Start Date 2023-09-11
Primary Completion 2027-08-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 89 Years
Study Type INTERVENTIONAL
Interventions
Instructor-led, one-on-one M2M exercise groupSelf-guided control with pre-recorded standard exercise videos

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 132 participants in total. It began in 2023-09-11 with a primary completion date of 2027-08-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study aims to test the benefits of a 24-week, cardio-emphasized Movement-to-Music exercise program for reversing cardiometabolic health risk factors compared to asynchronous, standard exercise programs among 132 adult wheelchair users. The targeted cardiometabolic health factors are waist circumference, triglycerides, "good" cholesterol, glucose, and blood pressure. Additionally, a 12-week follow-up phase (weeks 25-36) is included to see whether the gains are maintained.

Eligibility Criteria

Inclusion Criteria: 1. full-time or part-time use of a wheelchair device (manual wheelchair, power wheelchair, electric scooter) self-reported as the primary means of mobility 2. ≥ 2 cardiometabolic risk factor(s), 3. no contraindication to exercise as approved by a physician's medical clearance to exercise 4. age ≥18 years 5. able to use arms to exercise 6. obtaining \< 90 minutes of moderate-intensity aerobic exercise per week in the last month 7. not enrolled in a structured exercise program in the past 6 months 8. able to converse and read in English. Exclusion Criteria: 1. medically unstable to perform home exercise as determined by their physician 2. high-level tetraplegia and unable to use arms to exercise 3. no internet access was determined via self-report and internet speed test.

Contact & Investigator

Central Contact

Jereme Wilroy, PhD

✉ jdwilroy@uab.edu

📞 (205) 934-0355

Principal Investigator

Jereme Wilroy, PhD

PRINCIPAL INVESTIGATOR

The University of Alabama at Birmingham

Frequently Asked Questions

Who can join the NCT05606432 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Cardiometabolic Risk Factors in Adult Wheelchair Users. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05606432 currently recruiting?

Yes, NCT05606432 is actively recruiting participants. Contact the research team at jdwilroy@uab.edu for enrollment information.

Where is the NCT05606432 trial being conducted?

This trial is being conducted at Birmingham, United States.

Who is sponsoring the NCT05606432 clinical trial?

NCT05606432 is sponsored by University of Alabama at Birmingham. The principal investigator is Jereme Wilroy, PhD at The University of Alabama at Birmingham. The trial plans to enroll 132 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology